Cargando…
Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru
BACKGROUND: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260790/ https://www.ncbi.nlm.nih.gov/pubmed/25489950 http://dx.doi.org/10.1371/journal.pone.0112789 |
_version_ | 1782348225460568064 |
---|---|
author | Cáceres, Omar Rastogi, Nalin Bartra, Carlos Couvin, David Galarza, Marco Asencios, Luis Mendoza-Ticona, Alberto |
author_facet | Cáceres, Omar Rastogi, Nalin Bartra, Carlos Couvin, David Galarza, Marco Asencios, Luis Mendoza-Ticona, Alberto |
author_sort | Cáceres, Omar |
collection | PubMed |
description | BACKGROUND: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosis (XDR-TB) have been detected. Little information exists about the genetic diversity of drug-susceptible vs. MDR-TB and XDR-TB. METHODS: Cryopreserved samples of XDR strains from 2007 to 2009 (second semester), were identified and collected. Starting from 227 frozen samples, a total of 142 XDR-TB strains of Mycobacterium tuberculosis complex (MTBC; 1 isolate per patient) were retained for this study. Each strain DNA was analyzed by spoligotyping and the 15-loci Mycobacterial Interspersed Repetitive Unit (MIRU-15). RESULTS: Among the 142 isolates analyzed, only 2 samples (1.41%) could not be matched to any lineage. The most prevalent sublineage was Haarlem (43.66%), followed by T (27.46%), LAM (16.2%), Beijing (9.15%), and X clade (1.41%). Spoligotype analysis identified clustering for 128/142 (90.1%) isolates vs. 49/142 (34.5%) with MIRUs. Of the samples, 90.85% belonged to retreated patients. The drug resistant profile demonstrated that 62.67% showed resistance to injectable drugs capreomycin (CAP) and kanamycin (KAN) vs. 15.5% to CAP alone and 21.8% to KAN alone. The SIT219/T1 and SIT50/H3 were the most prevalent patterns in our study. The spoligoforest analysis showed that SIT53/T1 was at the origin of many of the T lineage strains as well as a big proportion of Haarlem lineage strains (SIT50/H3, followed by SIT47/H1, SIT49/H3, and SIT2375/H1), as opposed to the SIT1/Beijing strains that did not appear to evolve into minor Beijing sublineages among the XDR-TB strains. CONCLUSION: In contrast with other Latin-American countries where LAM sublineage is the most predominant, we found the Haarlem to be the most common followed by T sublineage among the XDR-TB strains. |
format | Online Article Text |
id | pubmed-4260790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42607902014-12-15 Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru Cáceres, Omar Rastogi, Nalin Bartra, Carlos Couvin, David Galarza, Marco Asencios, Luis Mendoza-Ticona, Alberto PLoS One Research Article BACKGROUND: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosis (XDR-TB) have been detected. Little information exists about the genetic diversity of drug-susceptible vs. MDR-TB and XDR-TB. METHODS: Cryopreserved samples of XDR strains from 2007 to 2009 (second semester), were identified and collected. Starting from 227 frozen samples, a total of 142 XDR-TB strains of Mycobacterium tuberculosis complex (MTBC; 1 isolate per patient) were retained for this study. Each strain DNA was analyzed by spoligotyping and the 15-loci Mycobacterial Interspersed Repetitive Unit (MIRU-15). RESULTS: Among the 142 isolates analyzed, only 2 samples (1.41%) could not be matched to any lineage. The most prevalent sublineage was Haarlem (43.66%), followed by T (27.46%), LAM (16.2%), Beijing (9.15%), and X clade (1.41%). Spoligotype analysis identified clustering for 128/142 (90.1%) isolates vs. 49/142 (34.5%) with MIRUs. Of the samples, 90.85% belonged to retreated patients. The drug resistant profile demonstrated that 62.67% showed resistance to injectable drugs capreomycin (CAP) and kanamycin (KAN) vs. 15.5% to CAP alone and 21.8% to KAN alone. The SIT219/T1 and SIT50/H3 were the most prevalent patterns in our study. The spoligoforest analysis showed that SIT53/T1 was at the origin of many of the T lineage strains as well as a big proportion of Haarlem lineage strains (SIT50/H3, followed by SIT47/H1, SIT49/H3, and SIT2375/H1), as opposed to the SIT1/Beijing strains that did not appear to evolve into minor Beijing sublineages among the XDR-TB strains. CONCLUSION: In contrast with other Latin-American countries where LAM sublineage is the most predominant, we found the Haarlem to be the most common followed by T sublineage among the XDR-TB strains. Public Library of Science 2014-12-09 /pmc/articles/PMC4260790/ /pubmed/25489950 http://dx.doi.org/10.1371/journal.pone.0112789 Text en © 2014 Cβceres et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Cáceres, Omar Rastogi, Nalin Bartra, Carlos Couvin, David Galarza, Marco Asencios, Luis Mendoza-Ticona, Alberto Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru |
title | Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru |
title_full | Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru |
title_fullStr | Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru |
title_full_unstemmed | Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru |
title_short | Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru |
title_sort | characterization of the genetic diversity of extensively-drug resistant mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in peru |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260790/ https://www.ncbi.nlm.nih.gov/pubmed/25489950 http://dx.doi.org/10.1371/journal.pone.0112789 |
work_keys_str_mv | AT caceresomar characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu AT rastoginalin characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu AT bartracarlos characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu AT couvindavid characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu AT galarzamarco characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu AT asenciosluis characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu AT mendozaticonaalberto characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu |